Nanobac Life Sciences Prepares for FDA Clinical Trials

Nanobac Life Sciences, Inc. have announced the signing of a Manufacturing Agreement with Medicorp, Inc., for the production of two blood tests for the detection of Nanobacteria.

Nanobac is transferring production of both the Nano-Capture ELISA assay and the Nano-Sero IgG ELISA assay from its Nanobac Oy research laboratory in Kuopio, Finland to Medicorp in preparation for FDA clinical trials and expanded distribution.

Medicorp is Canada's largest, independent ISO 9001-certified manufacturer and distributor of immunodiagnostic and microbiology products.

Nanobac has already signed a distribution agreement with Oxoid Ltd. for territories in Europe, Brazil and Australia.